Norges Bank Bausch & Lomb Corp Transaction History

Norges Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2024	BUY	$16.8 - $20.99 $7.74 Million - $9.67 Million	460,545 New	460,545 $7.81 Million
Q3 2023 Nov 13, 2023	SELL	$16.8 - $20.99 $47 Million - $58.8 Million	-2,800,000 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$16.03 - $20.07 $18 Million - $22.5 Million	1,120,512 New	1,120,512 $22.5 Million
Q2 2023 Aug 14, 2023	SELL	$16.03 - $20.07 $51.8 Million - $64.9 Million	-3,234,219 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$15.67 - $18.91 $22.2 Million - $26.8 Million	1,416,193 New	1,416,193 $24.7 Million
Q4 2022 Feb 14, 2023	BUY	$13.5 - $17.14 $37.8 Million - $48 Million	2,800,000 New	2,800,000 $43.4 Million
Q3 2022 Nov 13, 2023	BUY	$14.23 - $17.76 $39.8 Million - $49.7 Million	2,800,000 New	2,800,000 $44.7 Million
Q2 2022 Aug 14, 2023	BUY	$13.36 - $20.0 $43.2 Million - $64.7 Million	3,234,219 New	3,234,219 $49.3 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.